The FDA has approved TNKase, a new, fast-acting stroke treatment that dissolves blood clots more efficiently, marking a significant advancement in stroke therapy and clot-busting technology.

I took Elly De La Cruz with the fourth pick of a draft, making him the first player selected after the obvious top three of ...

Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration (FDA) has approved TNKase® (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment ...

A new Georgetown University Medical Center study exploring a new brain imaging technique is bringing stroke experts a step ...

Crystal Palace's hopes of avoiding relegation from the Women's Super League were dented by Sunday's home defeat by Liverpool.

World record signing Naomi Girma makes her debut for Chelsea, who have to come from behind to salvage a draw at Brighton in ...

A new 15-minute tool to screen stroke survivors for visual perception problems has been launched by researchers from Durham ...

Stroke-induced aphasia significantly impacts communication and quality of life. Despite the standard treatment being speech and language therapy, outcomes vary, highlighting the need for additional ...

It’s a heart versus head thing. People in the south know full ... government will have a total expenditure of £100bn, so at a stroke reunification would increase this expenditure by 10 to ...